Clinical Trials Browser

Observational × Bevacizumab × 30 days × Clear all

NCT07527832 2026-05-22

An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.

Gastrointestinal

Hemorrhage, Colorectal Neoplasms

NCT06117891 2026-05-12

REFINE-IO

Active not recruiting

Gastrointestinal

Unresectable Hepatocellular Carcinoma